drugset / Trial / NCT03682393

Post-operative Corticosteroid Treatment After Mitral Valve Surgery

NCT03682393

Phase 2/3 Withdrawn Kuopio University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of the study is to intestigate whether three days intravenous corticosteroid management prevent atrial fibrillations in adults after mitral valve surgery. Prospective double-blinded randmized international multicenter study.

Timeline

Start
2020-01-01
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 100 mg Intravenous

Indications